Your browser doesn't support javascript.
loading
Clinical Management of Hospitalized Patients With High-Consequence Infectious Diseases in England.
Alonso, Alejandra; Cohen, Jonathan; Cole, Joby; Emonts, Marieke; Karunaharan, Natasha; Meadows, Chris; O'Hara, Geraldine; Owens, Stephen; Payne, Brendan; Porter, David; Ratcliffe, Libuse; Riordan, Andrew; Schmid, Matthias Ludwig; Sinha, Ruchi; Tunbridge, Anne; Whittaker, Elizabeth; Beadsworth, Mike; Dunning, Jake.
Afiliação
  • Alonso A; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Cohen J; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Cole J; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Emonts M; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Karunaharan N; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Meadows C; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • O'Hara G; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Owens S; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Payne B; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Porter D; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Ratcliffe L; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Riordan A; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Schmid ML; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Sinha R; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Tunbridge A; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Whittaker E; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Beadsworth M; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
  • Dunning J; Alejandra Alonso, MPH, is a Consultant in Paediatric Infectious Diseases, Department of Infection, Evelina London Children's Hospital; Jonathan Cohen, PhD, is a Consultant in Paediatric Immunology and Infectious Diseases, Department of Paediatric Immunology and Infectious Diseases, Evelina London Ch
Health Secur ; 22(S1): S50-S65, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39212633
ABSTRACT
Infectious disease physicians in England have been diagnosing and managing occasional cases of viral hemorrhagic fever since 1971, including the United Kingdom's first case of Ebola virus disease in 1976. Specialist isolation facilities to provide safe and effective care have been present since that time. Following the emergence of Middle East respiratory syndrome (MERS) in 2012, and the avian influenza A (H7N9) outbreak in 2013, and the 2014-2016 Ebola virus disease outbreak in West Africa, clinical and public health preparedness and response pathways in England have been strengthened for these types of diseases, now called high-consequence infectious diseases (HCIDs). The HCID program, led by NHS England and Public Health England between 2016 and 2018, helped to deliver these enhancements, which have since been used on multiple occasions for new UK cases and outbreaks of MERS, mpox, avian influenza, and Lassa fever. Additionally, HCID pathways were activated for COVID-19 during the first 3 months of 2020, before the pandemic had been declared and little was known about COVID-19 but HCID status had been assigned temporarily to COVID-19 as a precaution. The HCID program also led to the commissioning of a network of new airborne HCID treatment centers in England, to supplement the existing network of contact HCID treatment centers, which includes the United Kingdom's only 2 high-level isolation units. In this case study, the authors describe the airborne and contact HCID treatment center networks in England, including their formation and structures, their approach to safe and effective clinical management of patients with HCIDs in the United Kingdom, and challenges they may face going forward.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Health Secur Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Health Secur Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos